GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000981 describes the molecular function of sequence-specific DNA-binding proteins that modulate transcription of specific gene sets transcribed by RNA polymerase II.
• This activity is distinct from general/basal transcription factors such as TFIIA, TFIIB, TFIID and TFIIH, which act at core promoters but are not sequence-specific regulators.
• The function requires sequence-specific recognition of promoter or enhancer DNA elements and recruitment of coactivators or corepressors to regulate RNA polymerase II output.
• Dysregulation of RNA polymerase II-specific transcription factors is linked to cancer, fibrosis, developmental disorders and metabolic disease.
• CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression models are the primary tools for causal validation of these factors.
• GO:0000981 is a molecular_function term and should not be confused with broader GO terms such as transcription regulator activity or DNA-binding transcription factor activity without polymerase specificity.
Description
GO:0000981, DNA-binding transcription factor activity, RNA polymerase II-specific, is a Gene Ontology molecular_function term that captures the ability of a protein to bind specific DNA sequences and modulate transcription of target genes that are transcribed by RNA polymerase II. This term is central to understanding how cells convert extracellular and intracellular signals into precise changes in gene expression programs. Unlike general transcription factors that assemble at every RNA polymerase II promoter, proteins annotated with GO:0000981 recognize defined promoter-proximal or distal enhancer elements and regulate selected gene sets. The QuickGO definition states that this activity modulates the transcription of specific gene sets transcribed by RNA polymerase II, which distinguishes it from RNA polymerase I, II and III general machinery components and from non-specific DNA-binding proteins. Researchers use this term to annotate sequence-specific regulators such as nuclear receptors, homeodomain proteins, bZIP factors and zinc-finger proteins when direct experimental evidence supports their role in polymerase II-dependent transcription. Because these factors sit at the interface of signaling pathways and gene expression, they are heavily studied in cancer, fibrosis, immunology and developmental biology.
DNA-binding transcription factor activity, RNA polymerase II-specific At A Glance
| GO ID | GO:0000981 |
|---|---|
| GO term | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Ontology | molecular_function |
| Definition | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. |
| Synonym | RNA polymerase II transcription factor activity, sequence-specific DNA binding; transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding; zinc ion regulated core promoter proximal region sequence-specific DNA binding RNA polymerase II transcription factor activity. |
| Major function | Sequence-specific DNA binding at promoters or enhancers to activate or repress RNA polymerase II-dependent transcription. |
| Distinguishing feature | Polymerase II specificity and sequence-specific DNA recognition, unlike general transcription factors such as TFIIA or TFIIB. |
| Representative regulators | Sequence-specific activators and repressors including nuclear receptors and signal-responsive transcription factors. |
| Related disease areas | Cancer, fibrosis, developmental disorders and metabolic disease. |
What Is GO:0000981?
In practical terms, GO:0000981 describes a protein function: the protein binds a specific DNA sequence in a regulatory region and, through that binding, changes the transcription of one or more genes that are transcribed by RNA polymerase II. The activity is sequence-specific, meaning the factor does not bind all DNA equally but recognizes a defined motif or response element. It is polymerase II-specific, meaning the regulated genes are transcribed by RNA polymerase II rather than by RNA polymerase I or III. The term covers both activation and repression, because the defining feature is modulation of transcription, not the direction of the effect. It also covers factors that act through core promoter-proximal elements or distal enhancers, as reflected in the many synonym strings in QuickGO.
Why Is DNA-binding transcription factor activity, RNA polymerase II-specific Important in Cell Biology?
GO:0000981 is important because it defines the molecular function that connects signal transduction to selective gene expression. Proteins with this activity determine which messenger RNAs are produced by RNA polymerase II, thereby controlling cell fate, proliferation, differentiation, stress responses and metabolism. Because the activity is sequence-specific, it provides a mechanistic explanation for how a single stimulus can activate one gene set while leaving others unchanged. This makes the term essential for interpreting transcriptomic data, for annotating gene function, and for designing experiments that test causality between a transcription factor and a cellular phenotype.
• Defines sequence-specific regulation of RNA polymerase II-transcribed genes, a core mechanism of differential gene expression.
• Distinguishes true sequence-specific regulators from general transcription factors such as TFIIA and TFIIB.
• Provides the functional framework for interpreting enhancer and promoter activity in genomics.
• Links signaling pathways to transcriptional outputs in cancer, fibrosis and inflammation.
• Supports annotation of nuclear receptors and other ligand-regulated transcription factors.
• Enables causal testing of candidate regulators using CRISPR knockout and knock-in models.
• Helps prioritize variants in transcription factor genes for functional follow-up.
• Underpins the design of reporter assays and chromatin-based methods for studying regulatory DNA.
• Connects molecular function to disease phenotypes such as renal fibrosis and tumor progression.
• Guides bioinformatic enrichment of transcription factor networks from RNA-seq and ChIP-seq data.
Mechanism, Genes and Research Methods
Sequence-specific DNA recognition
In simple terms: The transcription factor first finds and binds a specific short DNA sequence in a promoter or enhancer.
The defining first step of GO:0000981 is sequence-specific binding of the transcription factor to a regulatory DNA element. This recognition is mediated by structured DNA-binding domains such as homeodomains, zinc fingers, basic leucine zippers or nuclear receptor DNA-binding domains. The affinity and specificity of this interaction determine which genes can be regulated in a given cell. QuickGO synonyms explicitly include core promoter proximal region and distal enhancer sequence-specific binding, reflecting that the same activity can occur at different regulatory locations. General transcription factors such as TFIIA and TFIIB also contact DNA and RNA polymerase II, but they are not sequence-specific regulators of selected gene sets, which is why they are not annotated with GO:0000981.
Coactivator and corepressor recruitment
In simple terms: After binding DNA, the factor recruits helper proteins that turn transcription up or down.
Once bound to its target element, a GO:0000981 protein modulates transcription by recruiting coactivators or corepressors. Coactivators such as PC4/Sub1 have multiple functions in RNA polymerase II transcription and can influence the efficiency of activation. Nuclear receptor factors such as RAR/RXR illustrate how ligand-dependent transcription depends on interactions with TBP and cofactors. The direction of the effect, activation or repression, depends on the specific cofactor complexes recruited and on the promoter context. This step is experimentally separable from DNA binding and is often the target of regulatory post-translational modifications.
Assembly of the RNA polymerase II preinitiation complex
In simple terms: The DNA-bound factor helps assemble the machinery that starts transcription by RNA polymerase II.
GO:0000981 activity ultimately influences assembly or stability of the RNA polymerase II preinitiation complex at the target promoter. General factors such as TFIIA and TFIIB are required for basal and activated transcription, and their functions have been dissected genetically and biochemically. Sequence-specific factors annotated with GO:0000981 act upstream of or in concert with this general machinery to increase or decrease the rate of initiation. The yeast TFIIA studies showed distinct functional regions and a polymerase II-specific role in basal and activated transcription, providing a mechanistic contrast to sequence-specific regulators. Similarly, TFIIB-related factors function in RNA polymerase III transcription, highlighting that polymerase specificity is a key annotation criterion.
Signal-dependent regulation of transcription factor activity
In simple terms: Signals inside the cell can switch the transcription factor on or off without changing its amount.
Many GO:0000981 proteins are regulated by signaling pathways that modify their localization, DNA-binding affinity or cofactor recruitment. Retinoid-dependent transcription through RAR/RXR and TBP illustrates how a small-molecule signal can control the assembly of an active transcription complex. In pathological settings such as renal fibrosis, signaling through AKT/IKKbeta/NFkappaB can influence transcription factor-driven gene programs. Computational analyses of transcription factor genes such as HIC1 have identified single nucleotide polymorphisms that may alter function, providing hypotheses for signal-dependent regulation. These examples show that GO:0000981 is not a static property but a regulated activity that integrates cellular signals.
Target gene selection and transcriptional output
In simple terms: The final result is a change in the set of genes that the cell expresses.
The functional output of GO:0000981 is modulation of specific gene sets transcribed by RNA polymerase II. This output is measured experimentally by changes in nascent or mature mRNA levels after perturbation of the transcription factor. Because the activity is sequence-specific, the affected gene set is determined by the presence of cognate DNA elements in regulatory regions. Studies of coactivators such as PC4/Sub1 demonstrate that the transcriptional output also depends on the available cofactor pool and on polymerase II elongation or initiation efficiency. In disease contexts, altered target gene selection can drive fibrosis or tumorigenesis, making this step a key focus for therapeutic intervention.
Key Genes Involved in GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
The following genes and proteins represent experimentally characterized factors whose functions relate to sequence-specific RNA polymerase II transcription, including general factors that provide mechanistic contrast and sequence-specific regulators relevant to GO:0000981.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TFIIA | General transcription factor that stabilizes TBP-DNA binding and supports basal and activated RNA polymerase II transcription | Mechanistic contrast to sequence-specific GO:0000981 factors; testis-specific TFIIAtau isoform studied in transcription activation |
| TFIIB | General transcription factor required for RNA polymerase II preinitiation complex assembly; TFIIB-related factor functions in RNA polymerase III | Defines polymerase specificity and basal machinery context for GO:0000981 regulators |
| TBP | TATA-binding protein that nucleates preinitiation complex assembly and is targeted by sequence-specific regulators | Central node for retinoid-dependent transcription and cofactor recruitment |
| PC4/Sub1 | Transcriptional coactivator with multiple functions in RNA polymerase II transcription | Model for how coactivators modulate output of DNA-bound transcription factors |
| RAR/RXR | Ligand-dependent nuclear receptor heterodimer that regulates transcription through TBP and cofactors | Prototype for signal-dependent GO:0000981 activity |
| HIC1 | Sequence-specific transcriptional repressor with computationally predicted functional SNPs | Candidate for variant-to-function studies using CRISPR knock-in |
| NFkappaB components | Signal-responsive transcription factors linked to AKT/IKKbeta signaling in renal fibrosis | Disease-relevant example of transcription factor-driven pathology |
| AraC/XylS family activators | Bacterial transcription activators that contact RNA polymerase alpha subunit | Comparative model for activation determinants, useful for mechanistic contrast |
| TFIIAtau | Testis-specific TFIIA isoform that stimulates TBP-DNA binding and transcription activation | Isoform-specific regulation of polymerase II transcription |
| Sub1 | Yeast coactivator with roles in initiation and elongation by RNA polymerase II | Genetic model for coactivator function in transcription |
| TFIIB-related factor | Involved in RNA polymerase III transcription, illustrating polymerase-specific machinery | Helps define boundaries of GO:0000981 annotation |
| RNA polymerase II alpha subunit | Target of class II-specific activation determinants in bacteria | Model for activator-polymerase contacts |
| TBP-associated factors | Components of the TFIID complex that interface with sequence-specific regulators | Relevant to cofactor recruitment mechanisms |
| Nuclear receptor coactivators | Mediate ligand-dependent activation of polymerase II transcription | Therapeutic targets in hormone-dependent disease |
| Chromatin modifiers | Enzymes recruited by DNA-bound factors to alter chromatin accessibility | Downstream effectors of GO:0000981 activity |
| Mediator complex subunits | Bridge sequence-specific factors and RNA polymerase II | Integration hub for transcriptional activation |
How Is DNA-binding transcription factor activity, RNA polymerase II-specific Regulated?
GO:0000981 activity is regulated at multiple levels. DNA-binding affinity can be modulated by post-translational modifications, ligand binding and partner protein interactions, as illustrated by retinoid-dependent RAR/RXR transcription. Cofactor availability, including PC4/Sub1 and TBP-associated factors, sets the threshold for activation or repression. Signaling pathways such as AKT/IKKbeta/NFkappaB can influence transcription factor-driven gene programs in disease states such as renal fibrosis. Genetic variation, including single nucleotide polymorphisms in transcription factor genes such as HIC1, can alter function and is a subject of computational and experimental study. Finally, the general transcription machinery, including TFIIA and TFIIB, provides the basal context within which sequence-specific regulation occurs.
DNA-binding transcription factor activity, RNA polymerase II-specific and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NFkappaB pathway components | Renal fibrosis and inflammatory signaling | Knockout or point-mutation models in renal cell lines and animal models |
| HIC1 | Cancer predisposition and transcriptional repression | CRISPR knock-in of SNPs and knockout for functional validation |
| RAR/RXR | Retinoid-dependent developmental and metabolic programs | Ligand-response reporter assays with knockout and overexpression |
| TBP | General transcription and nuclear receptor signaling | Point-mutation knock-in to dissect interaction surfaces |
| PC4/Sub1 | Transcription-associated growth control | Knockout and overexpression in yeast and mammalian cells |
Fibrosis and inflammatory signaling
Dysregulated RNA polymerase II-specific transcription factor activity contributes to fibrotic and inflammatory disease. In adenine-induced renal fibrosis, the AKT/IKKbeta/NFkappaB signaling pathway is implicated in disease progression, and transcription factors downstream of this pathway drive pro-fibrotic gene programs. This illustrates how GO:0000981 activity can convert chronic signaling into sustained changes in gene expression that promote tissue remodeling. Targeting such transcription factors or their upstream regulators is a potential therapeutic strategy.
Cancer and tumor progression
Sequence-specific transcription factors are frequently altered in cancer, where they can drive proliferation, survival and metastasis. Computational analysis of single nucleotide polymorphisms in the HIC1 gene, a transcriptional repressor, highlights how inherited or somatic variants in transcription factor genes may affect function and disease risk. Because GO:0000981 proteins control specific gene sets, their dysregulation can reprogram cancer cell transcriptomes. Functional validation of candidate variants using CRISPR-based models is a key research approach.
Developmental and metabolic disorders
Many developmental and metabolic programs depend on ligand-regulated and signal-responsive transcription factors. Retinoid-dependent transcription through RAR/RXR and TBP provides a paradigm for how nuclear receptors translate small-molecule signals into gene expression changes. Disruption of such factors can lead to developmental abnormalities or metabolic imbalance. Studying these factors with knockout and knock-in models helps establish causality between specific DNA-binding activities and organismal phenotypes.
From DNA-binding transcription factor activity, RNA polymerase II-specific-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the candidate transcription factor required for target gene expression? | CRISPR knockout cell line followed by RNA-seq |
| Does a specific DNA-binding domain residue mediate sequence specificity? | Point-mutation knock-in of the DNA-binding domain |
| Does a disease-associated SNP alter transcription factor function? | Knock-in of the variant allele and comparison with wild type |
| Where and when is the factor expressed and bound? | Tagged knock-in for imaging and chromatin immunoprecipitation |
| Does overexpression drive a gene expression program? | Doxycycline-inducible overexpression cell model |
| Which cofactors are required for activation? | Knockout of coactivator genes in a reporter background |
How to Study the DNA-binding transcription factor activity, RNA polymerase II-specific Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Changes in mRNA levels after perturbation | Identifying target gene sets of a transcription factor |
| ChIP-seq / ChIP-qPCR | Genomic binding sites of a transcription factor | Mapping sequence-specific DNA binding |
| Reporter assay | Transcriptional activity of a regulatory element | Testing promoter and enhancer function |
| CRISPR knockout | Loss-of-function phenotype | Testing requirement for a transcription factor |
| CRISPR knock-in | Effect of a specific variant or tag | Variant-to-function and imaging studies |
| Overexpression | Gain-of-function transcriptional output | Testing sufficiency of a factor |
| Computational SNP analysis | Predicted impact of variants on function | Prioritizing candidates for experimental validation |
| Co-immunoprecipitation | Protein-protein interactions | Identifying coactivator and corepressor partners |
Transcriptomic profiling by RNA-seq
RNA-seq measures the steady-state mRNA changes that result from altering a GO:0000981 factor. Knockout or knockdown of a candidate transcription factor followed by RNA-seq identifies the gene sets whose transcription depends on that factor. This approach is widely used to link sequence-specific DNA binding to transcriptional output and to prioritize target genes for further study.
Chromatin immunoprecipitation and binding assays
Chromatin immunoprecipitation followed by sequencing or quantitative PCR identifies genomic regions bound by a transcription factor. These methods test the sequence-specific DNA-binding component of GO:0000981 and can distinguish direct from indirect effects on transcription. Tagged knock-in models facilitate antibody-independent binding studies.
Reporter assays for regulatory elements
Reporter constructs containing candidate promoter or enhancer elements measure the ability of a transcription factor to modulate transcription in a controlled setting. Such assays are useful for dissecting core promoter proximal versus distal enhancer activity, as reflected in the QuickGO synonyms. They also allow structure-function mapping of DNA-binding and activation domains.
Computational variant and network analysis
Computational analysis of single nucleotide polymorphisms and transcription factor binding motifs can generate hypotheses about altered GO:0000981 activity. For example, in silico analysis of HIC1 variants prioritized potentially functional SNPs for experimental testing. Network and enrichment analyses of RNA-seq data can identify transcription factor modules and their target gene sets.
How CRISPR Can Be Used to Study GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
Knockout
CRISPR knockout generates loss-of-function alleles by introducing frameshift mutations in the coding sequence of a candidate transcription factor gene. This is the primary method for testing whether a GO:0000981 factor is required for expression of its target gene set and for a cellular phenotype. Knockout clones are typically validated by sequencing and by loss of protein detection, then analyzed by RNA-seq and phenotypic assays.
Point Mutation
Point-mutation knock-in introduces specific amino acid substitutions to dissect DNA-binding domain residues, activation domains or post-translational modification sites. This approach is essential for linking a specific molecular feature to GO:0000981 activity, such as sequence-specific DNA recognition or cofactor recruitment. Point mutants are compared with wild-type controls in reporter and transcriptomic assays.
Knock-in
Knock-in can be used to insert epitope tags, fluorescent proteins or disease-associated variants at the endogenous locus. Tagged knock-in enables imaging and chromatin immunoprecipitation of the transcription factor under native regulatory control. Variant knock-in allows direct comparison of disease-associated alleles with wild type in an isogenic background.
Overexpression
Overexpression models test whether increased levels of a transcription factor are sufficient to activate target gene sets or drive a phenotype. Inducible overexpression systems allow dose- and time-controlled experiments that complement loss-of-function studies. Overexpression is particularly useful for factors whose basal expression is low in the cell type of interest.
How EDITGENE Supports DNA-binding transcription factor activity, RNA polymerase II-specific Research
Researchers studying DNA-binding transcription factor activity, RNA polymerase II-specific-related genes often need to determine whether a candidate gene is causally involved in a transcriptional program or disease phenotype. EDITGENE provides CRISPR-based cell model services that enable knockout, point-mutation, knock-in and overexpression studies of transcription factor genes, together with library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for DNA-binding transcription factor activity, RNA polymerase II-specific research.
Frequently Asked Questions About DNA-binding transcription factor activity, RNA polymerase II-specific
What is GO:0000981?
GO:0000981 is the Gene Ontology molecular_function term for DNA-binding transcription factor activity, RNA polymerase II-specific. It describes proteins that bind specific DNA sequences and modulate transcription of gene sets transcribed by RNA polymerase II.
What genes are involved in DNA-binding transcription factor activity, RNA polymerase II-specific?
Genes involved include sequence-specific regulators such as nuclear receptors and signal-responsive factors, as well as general factors such as TFIIA, TFIIB and TBP that provide mechanistic context.
How is GO:0000981 different from general transcription factor activity?
GO:0000981 requires sequence-specific DNA binding and regulation of selected gene sets, whereas general factors such as TFIIA and TFIIB act at core promoters of many genes without sequence specificity.
What diseases are linked to RNA polymerase II-specific transcription factors?
Dysregulation has been linked to renal fibrosis through AKT/IKKbeta/NFkappaB signaling, cancer through factors such as HIC1, and developmental or metabolic disorders through nuclear receptors such as RAR/RXR.
How do researchers study GO:0000981?
Common methods include RNA-seq after knockout, ChIP-seq for binding sites, reporter assays for regulatory elements, and computational variant analysis.
Can CRISPR be used to study transcription factor function?
Yes. CRISPR knockout tests requirement, point-mutation knock-in dissects specific residues, tagged knock-in enables imaging and binding studies, and overexpression tests sufficiency.
What is the role of coactivators in GO:0000981?
Coactivators such as PC4/Sub1 are recruited by DNA-bound transcription factors and have multiple functions in RNA polymerase II transcription, influencing activation efficiency.
Why is polymerase II specificity important?
Polymerase II specificity distinguishes genes transcribed by RNA polymerase II from those transcribed by RNA polymerase I or III, and it is a key annotation criterion for GO:0000981.
What experimental models are suitable for transcription factor research?
Knockout, point-mutation knock-in, tagged knock-in and inducible overexpression cell models are widely used, complemented by RNA-seq and ChIP-based assays.
How can EDITGENE help with GO:0000981 research?
EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression, library screening and bioinformatics services to support causal studies of transcription factor function.
Conclusion
GO:0000981 defines the sequence-specific, RNA polymerase II-dependent transcription factor activity that converts cellular signals into selective gene expression programs. Its mechanistic dissection relies on distinguishing sequence-specific regulators from general transcription machinery and on using CRISPR-based models to test causality. Understanding this activity is essential for interpreting transcriptomic data and for developing therapeutic strategies in cancer, fibrosis and other diseases.
References
- 1. Zeng L et al.. 2024. Siling decoction ameliorates adenine-induced renal fibrosis in rats by the AKT/IKKβ/NFκB signaling pathway.. Phytomedicine 135:156228 PMID: 39550923
- 2. Ozer J et al.. 2000. A testis-specific transcription factor IIA (TFIIAtau) stimulates TATA-binding protein-DNA binding and transcription activation.. J Biol Chem 275(1):122-8 PMID: 10617594
- 3. Calvo O et al.. 2005. The transcriptional coactivator PC4/Sub1 has multiple functions in RNA polymerase II transcription.. EMBO J 24(5):1009-20 PMID: 15692559
- 4. Colbert T et al.. 1992. A yeast TFIIB-related factor involved in RNA polymerase III transcription.. Genes Dev 6(10):1940-9 PMID: 1398071
- 5. Annanya A et al.. 2024. Computational Analysis of Single Nucleotide Polymorphisms in Human HIC1 Gene.. Cureus 16(3):e56664 PMID: 38646326
- 6. Kang JJ et al.. 1995. Analysis of the yeast transcription factor TFIIA: distinct functional regions and a polymerase II-specific role in basal and activated transcription.. Mol Cell Biol 15(3):1234-43 PMID: 7862117
- 7. Meyer M et al.. 1996. Retinoid-dependent transcription: the RAR/RXR-TBP-EIA/EIA-LA connection.. Biochem Soc Symp 62:97-109 PMID: 8971343
- 8. Egan SM et al.. 2000. Transcription activation by a variety of AraC/XylS family activators does not depend on the class II-specific activation determinant in the N-terminal domain of the RNA polymerase alpha subunit.. J Bacteriol 182(24):7075-7 PMID: 11092872
